Annual Drug Patent Expirations for ALUNBRIG
Alunbrig is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has seventy-four patent family members in thirty-seven countries.
The generic ingredient in ALUNBRIG is brigatinib. One supplier is listed for this compound. Additional details are available on the brigatinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
